-
-
-
-
-
-
-
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress
-
-
-
-
-
-
-
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress
-
-
-
-
-
-
-
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results
-
-
-
-
-
-
-
Aurinia Pharmaceuticals (AUPH) Tops Q3 EPS by 8c
-
-
-
-
-
-
-
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stronghold, Aurinia, Lilium, and Li-Cycle and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Aurinia Reports First Quarter 2022 Financial and Operational Results
-
1,199,633 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

